LRRK2 Gly2019Ser penetrance in Arab-Berber patients from Tunisia: a case-control genetic study. - Wikidata - wikimedia - TriplyDB

LRRK2 Gly2019Ser penetrance in Arab-Berber patients from Tunisia: a case-control genetic study.

LRRK2 Gly2019Ser penetrance in Arab-Berber patients from Tunisia: a case-control genetic study.

http://www.wikidata.org/entity/Q39086510

about

Genetic perspective on the role of the autophagy-lysosome pathway in Parkinson disease Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic mice Heterodimerization of Lrrk1-Lrrk2: Implications for LRRK2-associated Parkinson disease Membrane localization of LRRK2 is associated with increased formation of the highly active LRRK2 dimer and changes in its phosphorylation Adult neurogenesis and neurite outgrowth are impaired in LRRK2 G2019S mice Ten years and counting: moving leucine-rich repeat kinase 2 inhibitors to the clinic Genetics of Parkinson's disease - a clinical perspective Is inhibition of kinase activity the only therapeutic strategy for LRRK2-associated Parkinson's disease?Progressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock-in mice Gene-environment interactions: key to unraveling the mystery of Parkinson's disease Parkinson's Disease and Cognitive Impairment Conditional expression of Parkinson's disease-related R1441C LRRK2 in midbrain dopaminergic neurons of mice causes nuclear abnormalities without neurodegeneration LRRK2 in Parkinson's disease - drawing the curtain of penetrance: a commentary.LRRK2 G2019S Mutation: Prevalence and Clinical Features in Moroccans with Parkinson's Disease.Abrogation of α-synuclein-mediated dopaminergic neurodegeneration in LRRK2-deficient rats.Using KASP technique to screen LRRK2 G2019S mutation in a large Tunisian cohort.LRRK2 parkinsonism in Tunisia and Norway: a comparative analysis of disease penetrance.LRRK2 variation and Parkinson's disease in African Americans.Parkinson's disease: Exit toxins, enter genetics Novel pathogenic LRRK2 p.Asn1437His substitution in familial Parkinson's disease.Glucocerebrosidase mutations are not a common risk factor for Parkinson disease in North Africa.Clinical expression of LRRK2 G2019S mutations in the elderly.Genetic variants ofLRRK2 in Taiwanese Parkinson's disease Reorganization of corticostriatal circuits in healthy G2019S LRRK2 carriers.A comparative study of Lrrk2 function in primary neuronal cultures.Genetic variation of the mitochondrial complex I subunit NDUFV2 and Parkinson's disease Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study.Asian perspectives on the recognition and management of levodopa 'wearing-off' in Parkinson's disease.Age-specific penetrance of LRRK2 G2019S in the Michael J. Fox Ashkenazi Jewish LRRK2 Consortium.Novel recruitment strategy to enrich for LRRK2 mutation carriers The Ever-Changing Morphology of Hippocampal Granule Neurons in Physiology and Pathology Inhibition of LRRK2 kinase activity leads to dephosphorylation of Ser(910)/Ser(935), disruption of 14-3-3 binding and altered cytoplasmic localization Leucine-rich repeat kinase 2 mutations and Parkinson's disease: three questions.Targets for neuroprotection in Parkinson's disease Emerging pathways in genetic Parkinson's disease: tangles, Lewy bodies and LRRK2.Abnormal localization of leucine-rich repeat kinase 2 to the endosomal-lysosomal compartment in lewy body disease.Dependence of leucine-rich repeat kinase 2 (LRRK2) kinase activity on dimerization.Genetics of Parkinson disease and essential tremor LRRK2, a puzzling protein: insights into Parkinson's disease pathogenesis Genetics and genomics of Parkinson's disease.

P2860

Q22242985-582AEF0F-CEB3-4103-9064-DA15BDEF6C7A Q24293070-E893CD79-BC25-41AE-8B87-D47394B7C120 Q24298781-26FE88D4-B18B-4FE2-8ED1-A629BC139782 Q24316270-9B5B93B8-B357-4084-B698-51470DBF825C Q24317631-716A5FAE-1386-468F-9B1D-921FC4857487 Q27007413-551AF0C5-A773-4962-8C56-0305B2D47AAD Q27022109-53FF4201-D12B-4C94-9A84-D7FBF7F915A9 Q27026262-3AEA8D01-848B-47C4-91B2-156ABF2DF02E Q27308060-C8D640BD-DF14-428F-910A-7429CB4AD2B5 Q28388674-5B95FBCA-E5EB-4EF9-A30F-C3892850A8A9 Q30239814-0B3E08B4-EDE7-4E16-AADC-D9EC67D786C1 Q30653185-B06DB406-7DF0-4FFA-9BF7-E5A479C52E1A Q33382857-8B44187A-1C3B-4E47-8E4D-58E611E865DC Q33561039-A90193B8-4477-410F-B075-12D55BE380AC Q33835006-3ADC0219-53E2-4A16-84C7-CE49C0E6DC89 Q33884044-24621E89-A163-47C0-B3D3-F55C21DFD9A5 Q34079325-B3B73729-10F8-4DDF-BB74-E38AB9DCC1E6 Q34126355-4C221DE3-D85D-47EA-817C-42507BBEC25D Q34140428-19C3A6C6-44A2-4DE8-96F9-88B6E46E93E7 Q34267681-4EEA0D53-3AA1-4039-8A21-E11D51369FA5 Q34267725-6EC714A0-AA62-4E62-B96C-56FCA6E20EE4 Q34300290-0DB705D5-935E-45C1-8796-9FC10056C295 Q35067666-63D4C698-6E28-4FB5-A2C6-D454FCB5414D Q35106295-0A1DCD90-798C-4CDE-9529-591E36DD63BB Q35176338-CDD9B4A6-65A6-4E20-BBAF-B4446BEBC7B4 Q35240670-7F0716F4-8D55-4A10-AEEF-4A77A7DDCA82 Q35525896-9606A7EE-1B16-4017-A3F4-2C39D18F17E1 Q35781883-5F883C54-D49E-46F6-912C-5E0D54386829 Q35850713-062A1045-1530-45D4-B562-114C59D8D74C Q36098631-4AF51804-C436-40CB-99F6-3152A3EC3764 Q36475393-E33D1C2D-536D-4774-8975-606BB178A335 Q36780383-49B449BB-8ACF-4EA8-878F-57550B1470AC Q37225356-B1F91D3F-8297-4C03-83FE-75800DDFA76C Q37302453-FB7F49A6-25F9-4887-8A77-AA562C97E99D Q37330540-32A1A539-5738-4D0D-BB0C-D7D6F16271CF Q37402225-594EC018-C380-4318-B9BD-DAA634C8F9F8 Q37479332-38E467AB-AA38-4723-9DDE-1E9E00CBEB4D Q37594762-7097D880-D89B-4FC9-B5D4-A12D6D723049 Q38218398-A47D774C-AC93-4385-89AF-1B71EF144F90 Q38233866-80063CFF-BFE7-4596-AFEF-8E710C1E5B96

P2860

LRRK2 Gly2019Ser penetrance in Arab-Berber patients from Tunisia: a case-control genetic study.

http://www.wikidata.org/entity/Q39086510

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

LRRK2 Gly2019Ser penetrance in ...... a case-control genetic study.

@en

LRRK2 Gly2019Ser penetrance in ...... a case-control genetic study.

@nl

type

label

LRRK2 Gly2019Ser penetrance in ...... a case-control genetic study.

@en

LRRK2 Gly2019Ser penetrance in ...... a case-control genetic study.

@nl

altLabel

LRRK2 Gly2019Ser penetrance in ...... : a case-control genetic study

@en

prefLabel

LRRK2 Gly2019Ser penetrance in ...... a case-control genetic study.

@en

LRRK2 Gly2019Ser penetrance in ...... a case-control genetic study.

@nl

P1433

Q39086510-1E2324C0-1101-40B5-BB18-65991528195A

P1476

Q39086510-CE4426AE-4E44-4895-A4C0-2630407ABE9E

P2093

Q39086510-107D6052-ECF1-4CD3-9E00-F08AD47A794B

Q39086510-2DFF8646-71D9-4E56-A30F-E3CC14F9F32D

Q39086510-6EBCE755-8FD7-4048-9D4A-4A886A855559

Q39086510-7A0C04CC-440D-4C29-A3FF-C0F51FA1F2A0

Q39086510-BBA86011-F19F-47CB-9561-3E93CD697365

Q39086510-C1CA1FF4-B376-4E38-94C4-5876C0612D57

Q39086510-CC1F2784-2977-4D74-95AD-8D7222392B0E

Q39086510-E5E974D7-8FE4-4B95-AC19-0A9195B58274

Q39086510-F23F94A8-4348-4613-BC09-E4AF64826F67

Q39086510-F93F8982-FDF9-4ADA-B65B-D873016D8CBC

P304

Q39086510-DAB28EEF-6DE3-45F4-B130-3FE818CC9ED9

P31

Q39086510-492ADF16-44F6-4E1A-AE3E-882F9B735075

P356

Q39086510-963B4826-BEB8-431B-8AB1-2297127E0CDE

P4011

Q39086510-8E44A76F-DB30-4716-9EE8-4E130E1B065F

P407

Q39086510-A8FCF421-0582-46A0-A209-E18EEF7639C7

P433

Q39086510-29713772-5CC4-495F-8D1E-EAE85FD1568F

P478

Q39086510-A6911E25-7F91-48B4-B9A5-255DFA1A53B5

P50

Q39086510-4FA8A260-31D6-4C3F-A502-C0622D060F61

Q39086510-981EE926-15FD-4AD8-9665-EEA1AD5C01AB

Q39086510-B3ABB64B-ADE7-443C-91B7-2E4A92AE4FF0

Q39086510-BC04DFDF-5EED-42E5-810F-7E6D855789BB

Q39086510-C8305091-82A2-4B23-9E04-95404BC8A060

Q39086510-CC896799-A7CB-446E-AC03-ECB4BB1014BF

Q39086510-D80D5FA9-E26D-4E25-A267-986C7A98C4EF

Q39086510-F111279F-BA97-4E32-9E54-558E20AC3E3C

P577

Q39086510-C73859B7-7627-4EFC-A5A6-D0D805A0DB03

P698

Q39086510-B5B816D9-8441-4120-AA8E-FA2E9620AC9D

P356

S1474-4422(08)70116-9

P1433

Lancet Neurology

P1476

LRRK2 Gly2019Ser penetrance in ...... a case-control genetic study.

@en

P2093

Fayçal Hentati

http://www.w3.org/2001/XMLSchema#string

Ghada El Euch-Fayeche

http://www.w3.org/2001/XMLSchema#string

Lefkos T Middleton

http://www.w3.org/2001/XMLSchema#string

Mounir Kefi

http://www.w3.org/2001/XMLSchema#string

Mourad Zouari

http://www.w3.org/2001/XMLSchema#string

Rab K Prinjha

http://www.w3.org/2001/XMLSchema#string

Rim Amouri

http://www.w3.org/2001/XMLSchema#string

Ruchi Upmanyu

http://www.w3.org/2001/XMLSchema#string

Samia Ben Sassi

http://www.w3.org/2001/XMLSchema#string

Samia Ben Yahmed

http://www.w3.org/2001/XMLSchema#string

P304

591-594

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S1474-4422(08)70116-9

http://www.w3.org/2001/XMLSchema#string

P4011

5e6a0dab4808a3ed6e37c56f11a38b3b489bac2d

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Matthew J. Farrer

Paul M. Matthews

Rachel A Gibson

L Ishihara-Paul

P577

2008-06-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18539535

http://www.w3.org/2001/XMLSchema#string